CuraePharma360

CuraePharma360 is a specialty pharmaceutical company focused on improving patient access to affordable medications through a disruptive direct-to-patient delivery model. The company aims to lower the cost of high-priced specialty drugs by streamlining the supply chain and removing traditional intermediaries like pharmacy benefit managers. Their primary offering includes specialty generics, such as Teriparatide for osteoporosis, provided at transparent, lower-than-market prices. By integrating pharmacy services with direct distribution, CuraePharma360 ensures better medication adherence and financial relief for patients with chronic conditions.